---
gsd_state_version: 1.0
milestone: v1.0
milestone_name: milestone
status: verifying
stopped_at: Completed 02-02-PLAN.md
last_updated: "2026-06-17T10:53:55.893Z"
last_activity: 2026-06-17
progress:
  total_phases: 5
  completed_phases: 2
  total_plans: 6
  completed_plans: 6
  percent: 40
---

# Project State

## Project Reference

See: .planning/PROJECT.md (updated 2026-06-16)

**Core value:** Produce a defensible TR Part E manuscript package in which every claim, table, figure, and positioning statement is traceable to the formal Phase 6 evidence or is clearly labeled as diagnostic, exploratory, or a limitation.
**Current focus:** Phase 02 - tr-e-positioning-lock-and-claim-ledger

## Current Position

Phase: 02 (tr-e-positioning-lock-and-claim-ledger) - EXECUTING
Plan: 3 of 3
Status: Phase complete — ready for verification
Last activity: 2026-06-17

Progress: [██████████] 100%

## Performance Metrics

**Velocity:**

- Total plans completed: 4
- Average duration: N/A
- Total execution time: 0.0 hours

**By Phase:**

| Phase | Plans | Total | Avg/Plan |
|-------|-------|-------|----------|
| 1 | 3/3 | N/A | N/A |
| 2 | 1/3 | 4 min | 4 min |

**Recent Trend:**

- Last 5 plans: 02-01 (4 min)
- Trend: N/A

| Phase 02 P02-02 | not_tracked_from_start | 3 tasks | 1 files |
| Phase 02 P02-03 | 9.8 minutes | 2 tasks | 2 files |

## Accumulated Context

### Decisions

Decisions are logged in PROJECT.md Key Decisions table.
Recent decisions affecting current work:

- Initialization: Target is TR Part E, not TR Part A.
- Initialization: `manuscript/` is canonical paper source.
- Initialization: `results/formal/phase06/` is canonical formal evidence.
- Initialization: Matched coverage, fixed accepted set, MILP, Gamma, and algorithm diagnostics are not headline evidence unless explicitly labeled.
- Planning revision: Phase 3 is structural/non-numeric for evidence-dependent claims; Phase 4 injects verified final numbers.
- Planning revision: Claim ledger must include source/script/command/formula/numerator/denominator and allowed/prohibited sentence fields.
- Planning revision: Submission-ready status requires hard verification and provenance gates.
- Phase 02 Plan 02-01: The manuscript is locked as operational service-design evidence for TR-E, not policy validation or optimization-method supremacy.
- Phase 02 Plan 02-01: `passenger-response-aware simulation framework` is the strongest allowed mechanism label.
- Phase 02 Plan 02-01: Diagnostic matched-coverage, fixed-accepted-set, Gamma/Pareto, and MILP evidence require explicit diagnostic qualifiers.
- Phase 02 Plan 02-01: `TR-E submission-ready` is reserved for Phase 5 after hard readiness gates pass.
- [Phase 02]: 02-02 ledger rows are occurrence-level and may share claim_family_id values for cross-section grouping. — Supports section-level edits without losing manuscript-location traceability.
- [Phase 02]: 02-02 matched coverage and fixed accepted-set evidence are diagnostic, not primary headline evidence. — Preserves the evidence-role boundary required for TR-E claim posture.
- [Phase 02]: 02-02 formal numerical claims stay as Phase 4 placeholders until source, denominator, and wording are verified. — Prevents Phase 2 from injecting final values before provenance verification.
- [Phase 02]: Claim statuses are limited to safe, safe_with_qualifier, downgrade_required, and blocker. - Plan 02-03 requires a closed status enum so later manuscript, provenance, and package phases route claims consistently.
- [Phase 02]: Old values 18.3%, 29.1%, 35.0%, and 0.1216 are blockers until Phase 4 verifies provenance. - Project constraints prohibit final numerical injection before Phase 4 verifies formal evidence, denominators, formulas, and allowed wording.
- [Phase 02]: Package-facing risks remain package_consistency or provenance-risk rows unless reused in submitted manuscript text. - Plan 02-03 keeps README, CLAUDE, cover, response, and figure-script comments separate from manuscript claim rows unless the text is reused for submission.

### Pending Todos

None yet.

### Blockers/Concerns

- README and manuscript metadata still contain TR Part A framing and must be revised during Phase 3.
- Existing codebase concerns note default `pytest` collection and dependency metadata risks that may affect verification.
- Phase 3 must not lock final numerical values before Phase 4 table/figure provenance checks.

## Deferred Items

| Category | Item | Status | Deferred At |
|----------|------|--------|-------------|
| Future evidence | Real Beijing public-data ingestion and empirical calibration | Deferred to v2 | Initialization |
| Future model | Endogenous Gamma and stronger exact benchmark | Deferred to v2 | Initialization |

## Session Continuity

Last session: 2026-06-17T10:53:17.591Z
Stopped at: Completed 02-02-PLAN.md
Resume file: None
